Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 1/2016

01-01-2016 | Original Article

Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects

Authors: Camelia Abdel-Malak, Hossam Darwish, Afaf Elsaid, Fatma El-Tarapely, Rami Elshazli

Published in: Familial Cancer | Issue 1/2016

Login to get access

Abstract

Colorectal cancer is a multifactorial disease that involves both environmental and genetic factors. The gene encoding adenomatous polyposis coli (APC) has been reported to be associated with colorectal cancer (CRC) risk in several ethnic populations. The aim of this work is to assess the association of the APC I1307K and E1317Q polymorphisms with CRC risk among Egyptian subjects. This study included 120 unrelated CRC Egyptian patients who were compared to 100 healthy controls from the same locality. For all subjects, DNA was genotyped for APC I1307K and E1317Q polymorphisms using the PCR-ARMS technique. The frequency of APC I1307K carrier (TA+AA genotypes) was noted to be significantly higher among cases with CRC compared to controls (18.3 vs. 9.0 %, OR 2.58, 95 % CI 1.09–6.09, p = 0.03). Also the frequency of the APC I1307K A allele was significantly higher among cases compared to controls (10.4 vs. 4.5 %, OR 2.47; 95 % CI 1.12–5.42, p = 0.03). On the contrast, the frequencies of APC E1317Q GC genotype and C allele showed no significant difference among CRC patients compared to controls (3.3 vs. 2.0 %, OR 1.69; 95 % CI 0.30–9.42, p = 0.69 and 2.1 vs. 1.0 %, OR 2.11; 95 % CI 0.40–10.97, p = 0.46, respectively). Cases of the APC I1307K and E1317Q carriers (TA+AA and GC) showed no significant difference compared to those with I1307K and E1317Q non-carriers (TT and GG) regarding their clinical and laboratory markers. APC I1307K variant was associated with an increased risk of CRC among Egyptian subjects.
Literature
1.
2.
3.
4.
Coppedè F, Lopomo A, Spisni R, Migliore L (2014) Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World J Gastroenterol 20(4):943–956PubMedPubMedCentralCrossRef
5.
Bertorelle R, Rampazzo E, Pucciarelli S, Nitti D, De Rossi A (2014) Telomeres, telomerase and colorectal cancer. World J Gastroenterol 20(8):1940–1950PubMedPubMedCentralCrossRef
6.
Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66(3):589–600PubMedCrossRef
7.
Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P et al (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328(6131):614–616PubMedCrossRef
8.
9.
Fodde R, Smits R, Clevers H (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1(1):55–67PubMedCrossRef
10.
Boursi B, Sella T, Liberman E, Shapira S, David M, Kazanov D, Arber N, Kraus S (2013) The APC p. I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews. Eur J Cancer 49(17):3680–3685PubMedCrossRef
11.
Liang J, Lin C, Hu F, Wang F, Zhu L, Yao X, Wang Y, Zhao Y (2013) APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol 177(11):1169–1179PubMedCrossRef
12.
Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17(1):79–83PubMedCrossRef
13.
Chen SP, Tsai ST, Jao SW, Huang YL, Chao YC, Chen YL, Wu CC, Lin SZ, Harn HJ (2006) Single nucleotide polymorphisms of the APC gene and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 29(6):83CrossRef
14.
Zhou XL, Eriksson U, Werelius B, Kressner U, Sun XF, Lindblom A (2004) Definition of candidate low risk APC alleles in a Swedish population. Int J Cancer 110(4):550–557PubMedCrossRef
15.
Figer A, Irmin L, Geva R, Flex D, Sulkes A, Friedman E (2001) Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer. Br J Cancer 85(4):523–526PubMedPubMedCentralCrossRef
16.
Kapitanović S, Cacev T, Radosević S, Spaventi S, Spaventi R, Pavelić K (2004) APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia. Exp Mol Pathol 77(3):193–200PubMedCrossRef
17.
Rozen P, Shomrat R, Strul H, Naiman T, Karminsky N, Legum C, Orr-Urtreger A (1999) Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 116(1):54–57PubMedCrossRef
18.
Drucker L, Shpilberg O, Neumann A, Shapira J, Stackievicz R, Beyth Y, Yarkoni S (2000) Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype. Cancer 88(4):755–760PubMedCrossRef
19.
Frayling IM, Beck NE, Ilyas M, Dove-Edwin I, Goodman P, Pack K, Bell JA, Williams CB, Hodgson SV, Thomas HJ, Talbot IC, Bodmer WF, Tomlinson IP (1998) The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci USA 95(18):10722–10727PubMedPubMedCentralCrossRef
20.
Fearnhead NS, Wilding JL, Winney B, Tonks S, Bartlett S, Bicknell DC, Tomlinson IP, Mortensen NJ, Bodmer WF (2004) Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci USA 101(45):15992–15997PubMedPubMedCentralCrossRef
21.
Cleary SP, Kim H, Croitoru ME, Redston M, Knight JA, Gallinger S, Gryfe R (2008) Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk. Dis Colon Rectum. 51(10):1467–1473; discussion 1473–4
22.
Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM (2009) American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 104(3):739–750PubMedCrossRef
23.
24.
Ohtani H (2007) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 21(7):4
25.
Compton CC (2003) Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 16(4):376–388PubMedCrossRef
26.
Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 17(7):2503–2516PubMedPubMedCentralCrossRef
27.
Popat S, Stone J, Coleman G, Marshall G, Peto J, Frayling I, Houlston R (2000) Prevalence of the APC E1317Q variant in colorectal cancer patients. Cancer Lett 149(1–2):203–206PubMedCrossRef
28.
Liberman E, Kraus S, Sagiv E, Dulkart O, Kazanov D, Arber N (2007) The APC E1317Q and I1307K polymorphisms in non-colorectal cancers. Biomed Pharmacother 61(9):566–569PubMedCrossRef
29.
Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359(6392):235–237PubMedCrossRef
30.
Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J (1997) Molecular biology of colorectal cancer. Curr Probl Cancer 21(5):233–300PubMedCrossRef
31.
Menéndez M, González S, Blanco I, Guinó E, Peris M, Peinado MA, Capellá G, Moreno V (2004) Colorectal cancer risk and the APC D1822V variant. Int J Cancer 112(1):161–163PubMedCrossRef
32.
Bougatef K, Marrakchi R, Ouerhani S, Sassi R, Moussa A, Kourda N, Blondeau Lahely Y, Najjar T, Ben Jilani S, Soubrier F, Ben Ammar Elgaaied A (2009) No evidence of the APC D1822V missense variant’s pathogenicity in Tunisian patients with sporadic colorectal cancer. Pathol Biol (Paris) 57(3):e67–e71CrossRef
33.
Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ (2005) APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidemiol Biomarkers Prev 14(4):863–870PubMedCrossRef
34.
Slattery ML, Samowitz W, Ballard L, Schaffer D, Leppert M, Potter JD (2001) A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer. Cancer Res 61(3):1000–1004PubMed
35.
Houlston RS, Tomlinson IP (2001) Polymorphisms and colorectal tumor risk. Gastroenterology 121(2):282–301PubMedCrossRef
36.
Lamlum H, Al Tassan N, Jaeger E, Frayling I, Sieber O, Reza FB, Eckert M, Rowan A, Barclay E, Atkin W, Williams C, Gilbert J, Cheadle J, Bell J, Houlston R, Bodmer W, Sampson J, Tomlinson I (2000) Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet 9(15):2215–2221PubMedCrossRef
37.
Murphy KM, Geiger T, Hafez MJ, Eshleman JR, Griffin CA, Berg KD (2003) A single nucleotide primer extension assay to detect the APC I1307K gene variant. J Mol Diagn 5(4):222–226PubMedPubMedCentralCrossRef
38.
Rozen P, Naiman T, Strul H, Taussky P, Karminsky N, Shomrat R, Samuel Z, Yaron Y, Orr-Urtreger A (2002) Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect. Cancer 94(10):2561–2568PubMedCrossRef
39.
Dundar M, Caglayan AO, Saatci C, Karaca H, Baskol M, Tahiri S, Ozkul Y (2007) How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population. Cancer Genet Cytogenet 177(2):95–97PubMedCrossRef
40.
Shtoyerman-Chen R, Friedman E, Figer A, Carmel M, Patael Y, Rath P, Fidder HH, Bar-Meir S, Theodor L (2001) The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect. Genet Test 5(2):141–146PubMedCrossRef
41.
Gryfe R, Di Nicola N, Lal G, Gallinger S, Redston M (1999) Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 64(2):378–384PubMedPubMedCentralCrossRef
42.
Stern HS, Viertelhausen S, Hunter AG, O’Rourke K, Cappelli M, Perras H, Serfas K, Blumenthall A, Dewar D, Baumann E, Lagarde AE (2001) APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews. Gastroenterology 120(2):392–400PubMedCrossRef
43.
Zauber NP, Sabbath-Solitare M, Marotta S, Zauber AG, Foulkes W, Chan M, Turner F, Bishop DT (2005) Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. Cancer 104(4):719–729PubMedCrossRef
44.
Gismondi V, Bonelli L, Sciallero S, Margiocco P, Viel A, Radice P, Mondini P, Sala P, Montera MP, Mareni C, Quaia M, Fornasarig M, Gentile M, Pietro G, Rossini P, Arrigoni A, Meucci GM, Bruzzi P, Varesco L (2002) Prevalence of the E1317Q variant of the APC gene in Italian patients with colorectal adenomas. Genet Test 6(4):313–317PubMedCrossRef
45.
Evertsson S, Lindblom A, Sun XF (2001) APC I1307K and E1317Q variants are rare or do not occur in Swedish colorectal cancer patients. Eur J Cancer 37(4):499–502PubMedCrossRef
46.
Hahnloser D, Petersen GM, Rabe K, Snow K, Lindor NM, Boardman L, Koch B, Doescher D, Wang L, Steenblock K, Thibodeau SN (2003) The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiol Biomarkers Prev 12(10):1023–1028PubMed
47.
Rozek LS, Rennert G, Gruber SB (2006) APC E1317Q is not associated with Colorectal Cancer in a population-based case-control study in Northern Israel. Cancer Epidemiol Biomarkers Prev 15(11):2325–2327PubMedCrossRef
48.
Prior TW, Chadwick RB, Papp AC, Arcot AN, Isa AM, Pearl DK, Stemmermann G, Percesepe A, Loukola A, Aaltonen LA, De La Chapelle A (1999) The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology 116(1):58–63PubMedCrossRef
49.
Hall MJ, Liberman E, Dulkart O, Galazan L, Sagiv E, Shmueli E, Kazanov D, Hallak A, Moshkowitz M, Figer A, Kraus S, Inbar M, Neugut AI, Arber N (2009) Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. Ann Oncol 20(9):1517–1521PubMedCrossRef
50.
Scott RJ, Crooks R, Rose L, Attia J, Thakkinstian A, Thomas L, Spigelman AD, Meldrum CJ (2004) Germline missense changes in the APC gene and their relationship to disease. Hered Cancer Clin Pract 2(2):81–91PubMedPubMedCentralCrossRef
Metadata
Title
Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects
Authors
Camelia Abdel-Malak
Hossam Darwish
Afaf Elsaid
Fatma El-Tarapely
Rami Elshazli
Publication date
01-01-2016
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2016
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-015-9834-8

Other articles of this Issue 1/2016

Familial Cancer 1/2016 Go to the issue

Short Communication

First report of somatic mosaicism for mutations in STK11 in four patients with Peutz–Jeghers syndrome

Original Article

Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned

Original Article

The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer

Original Article

Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary

Original Article

Screening of HELQ in breast and ovarian cancer families

Original Article

Genetic testing for Lynch syndrome: family communication and motivation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits